Epigenomics AG / Key word(s): AGM/EGMEpigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company 11-Sep-2023 / 15:54 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a […]
Year: 2023
11. September 2023
Epigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company
Read more
05. September 2023
Epigenomics AG: Pareto and Warburg publish analyst research reports
EQS-News: Epigenomics AG / Key word(s): Research UpdateEpigenomics AG: Pareto and Warburg publish analyst research reports 05.09.2023 / 17:20 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Pareto and Warburg publish analyst research reports Analysts consider acceptance of New Day Diagnostics’ purchase offer advantageous for shareholders Buy recommendation with price […]
10. August 2023
Epigenomics AG publishes financial results for the first six months 2023
EQS-News: Epigenomics AG / Key word(s): Half Year Report/Half Year ResultsEpigenomics AG publishes financial results for the first six months 2023 10.08.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for the first six months 2023 Berlin (Germany), August 10, 2023 – Epigenomics AG (FSE: […]
02. August 2023
Epigenomics AG: Capital reduction planned at a ratio of 5 : 1
Epigenomics AG / Key word(s): Corporate Action/MiscellaneousEpigenomics AG: Capital reduction planned at a ratio of 5 : 1 02-Aug-2023 / 10:36 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content […]
24. July 2023
Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets
EQS-News: Epigenomics AG / Key word(s): Strategic Company Decision/ContractEpigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets 24.07.2023 / 18:40 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets Acquirer is U.S. full-service diagnostics and CRO services company New Day […]
24. July 2023
Epigenomics AG: Agreement on the Acquisition of Almost All Assets
Epigenomics AG / Key word(s): Strategic Company Decision/ContractEpigenomics AG: Agreement on the Acquisition of Almost All Assets 24-Jul-2023 / 18:29 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of […]